EICHORPublic-registry site landscape for NCT06068946, “VK2735 for Weight Management Phase 2”, a Weight Loss study sponsored by Viking Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06068946 (registry record) |
| Study title | VK2735 for Weight Management Phase 2 |
| Official title | A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 13-week Study of VK2735 for Weight Management in Subjects Who Are Obese, or Overweight With at Least One Weight-related Comorbid Condition |
| Sponsor | Viking Therapeutics, Inc. |
| Condition(s) | Weight Loss |
| Phase | PHASE2 |
| Listed sites | 20 |
| Intervention(s) | VK2735, Placebo |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT06068946.
Eichor generates a preliminary site-risk snapshot for NCT06068946 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
More from Viking Therapeutics, Inc.
← Eichor home · All tracked trials · Weight Loss studies · Weekly briefs
